Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» myelofibrosis
myelofibrosis
Johnson & Johnson (JNJ) Strikes $935 Million Deal With Geron Corporation (GERN) To Co-Develop Imetelstat
Bidness Etc.
Mon, 11/24/14 - 10:08 am
JNJ
Geron
imetelstat
myelofibrosis
Incyte Building Blockbuster Drug One Disease At A Time
Investors.com
Mon, 11/17/14 - 04:05 pm
Incyte
Jakafi
myelofibrosis
Geron Collaborates with J&J for Imetelstat
Yahoo/Zacks
Sat, 11/15/14 - 09:42 am
Geron
JNJ
imetelstat
myelofibrosis
acute myelogenous leukemia
myelodysplastic syndrome
leukemia
Geron sells last drug in pipeline to J&J unit
Yahoo/Reuters
Thu, 11/13/14 - 07:14 pm
Geron
JNJ
imetelstat
Jakafi
myelofibrosis
After A Long Year, An Update on Geron's Myelofibrosis Drug Is Disclosed
TheStreet.com
Thu, 11/6/14 - 10:39 am
Geron
myelofibrosis
imetelstat
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis
Yahoo
Thu, 08/7/14 - 09:00 am
pacritinib
FDA
CTI BioPharma
fast track
myelofibrosis
Geron Set To Explode As FDA Releases Partial Clinical Hold On Imetelstat Myelofibrosis Trial
Seeking Alpha
Mon, 06/30/14 - 11:05 am
FDA
imetelstat
Geron
myelofibrosis
Geron And The Mayo Clinic Working In Parallel To Release Clinical Hold Of Imetelstat
Seeking Alpha
Sat, 05/3/14 - 11:15 am
Geron
imetelstat
myelofibrosis
Geron says FDA halts patient enrollment in another cancer trial
Yahoo/Reuters
Thu, 03/20/14 - 09:08 am
FDA
Geron
imetelstat
myelofibrosis
Clinical Trial Hold Of Geron's Revolutionary Drug Imetelstat Will Be Temporary
Seeking Alpha
Tue, 03/18/14 - 10:47 am
imetelstat
Geron
clinical trials
myelofibrosis
Geron Plummets as FDA Halts Development of Blood Disorder Drug
Bloomberg
Wed, 03/12/14 - 10:03 am
FDA
Geron
imetelstat
myelofibrosis
Geron Shares React to Imetelstat Mayo Study Update
TheStreet.com
Mon, 01/27/14 - 09:24 am
Geron
imetelstat
myelofibrosis
Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
Motley Fool
Tue, 12/10/13 - 11:36 am
Verastem
Cell Therapeutics
Novartis
Geron
imetelstat
Jakavi
myelofibrosis
tosedostat
AML
VS-5584
Geron Soars After Study Shows Bone Marrow Drug’s Benefit
Bloomberg
Fri, 12/6/13 - 09:11 am
Geron
imetelstat
myelofibrosis
Whither Sanofi R&D? Another Setback For An Oncology Drug
Pharmalot
Mon, 11/18/13 - 10:05 am
Sanofi
R&D
fedratinib
myelofibrosis
Baxter, Cell Therapeutics announce collaboration to develop pacritinib
Yahoo/Fly on the Wall
Fri, 11/15/13 - 08:43 am
Baxter International
pacritinib
Cell Therapeutics
JAK2/FLT3 inhibitors
solid tumors
myelofibrosis
Geron soars after myelofibrosis drug shows 44% response rate
The Fly on the Wall
Thu, 11/7/13 - 09:45 am
myelofibrosis
Geron
imetelstat
Incyte Has First-Mover Advantage
Motley Fool
Wed, 10/2/13 - 10:10 am
Incyte
myelofibrosis
Jakafi
Novartis
Myelofibrosis Battle: Novartis Vs. Sanofi
Seeking Alpha
Tue, 09/10/13 - 04:25 pm
Novartis
Sanofi
myelofibrosis
Jakafi
Incyte
SAR302503
This Biotech Has So Many Reasons to Be Liked
Motley Fool
Fri, 09/6/13 - 09:12 am
Incyte
JAK inhibitors
Jakafi
myelofibrosis
Pages
« first
‹ previous
1
2
3
next ›
last »